India, April 3 -- Shares of Aptevo Therapeutics Inc. (APVO) surged over 75% on Thursday morning after the clinical-stage biotechnology company announced it has entered into definitive securities purchase agreements for the purchase and sale of 1.76 million common shares in a registered direct offering and warrants to purchase up to 3.5 million common shares in a concurrent private placement at a combined purchase price of $1.19 per share and accompanying warrant.
APVO is currently trading at $2.4299, up $1.0499 or 76.1238%, on a huge volume of 52 million shares, above average volume of 0.5 million, on the Nasdaq. The stock opened its trading at $1.4800 after closing Wednesday at $1.3800. The stock has traded between $0.9420 and $180.1900 i...